Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3047% below fair value
$79.11−1.68 (-2.08%)
Close on Nov 20, 2026Market cap $32.69BP/E 13.0Yield 2.57%
Zoetis free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Zoetis's free cash flow for the twelve months ending Jun 30, 2026 was $2.32B, up 2.1% year over year. For fiscal 2025 it was $2.28B, down 0.7% from the year before. Over ten years it grew 17.9% a year on average. The highest annual figure on record is $2.30B in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.28B | -0.7% |
| FY2024 | Dec 31, 2024 | $2.30B | +41.8% |
| FY2023 | Dec 31, 2023 | $1.62B | +22.2% |
| FY2022 | Dec 31, 2022 | $1.33B | -23.6% |
| FY2021 | Dec 31, 2021 | $1.74B | +3.8% |
| FY2020 | Dec 31, 2020 | $1.67B | +25.3% |
| FY2019 | Dec 31, 2019 | $1.34B | -8.1% |
| FY2018 | Dec 31, 2018 | $1.45B | +29.4% |
| FY2017 | Dec 31, 2017 | $1.12B | +125.8% |
| FY2016 | Dec 31, 2016 | $497.00M | +13.0% |
| FY2015 | Dec 31, 2015 | $440.00M | -1.3% |
| FY2014 | Dec 31, 2014 | $446.00M | -10.3% |
| FY2013 | Dec 31, 2013 | $497.00M | +51.5% |
| FY2012 | Dec 31, 2012 | $328.00M | -9.4% |
| FY2011 | Dec 31, 2011 | $362.00M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $538.00M | +17.2% |
| Q1 FY2026 | Mar 31, 2026 | $291.00M | -13.6% |
| Q4 FY2025 | Dec 31, 2025 | $732.00M | +6.2% |
| Q3 FY2025 | Sep 30, 2025 | $755.00M | -3.7% |
| Q2 FY2025 | Jun 30, 2025 | $459.00M | +24.1% |
| Q1 FY2025 | Mar 31, 2025 | $337.00M | -25.9% |
| Q4 FY2024 | Dec 31, 2024 | $689.00M | -1.4% |
| Q3 FY2024 | Sep 30, 2024 | $784.00M | +35.4% |
| Q2 FY2024 | Jun 30, 2024 | $370.00M | +2076.5% |
| Q1 FY2024 | Mar 31, 2024 | $455.00M | +39.6% |
| Q4 FY2023 | Dec 31, 2023 | $699.00M | +22.6% |
| Q3 FY2023 | Sep 30, 2023 | $579.00M | +55.6% |
| Q2 FY2023 | Jun 30, 2023 | $17.00M | -91.1% |
| Q1 FY2023 | Mar 31, 2023 | $326.00M | +68.0% |
| Q4 FY2022 | Dec 31, 2022 | $570.00M | +11.5% |
| Q3 FY2022 | Sep 30, 2022 | $372.00M | -30.3% |
| Q2 FY2022 | Jun 30, 2022 | $190.00M | -48.4% |
| Q1 FY2022 | Mar 31, 2022 | $194.00M | -39.9% |
| Q4 FY2021 | Dec 31, 2021 | $511.00M | -9.7% |
| Q3 FY2021 | Sep 30, 2021 | $534.00M | +20.0% |
| Q2 FY2021 | Jun 30, 2021 | $368.00M | +5.7% |
| Q1 FY2021 | Mar 31, 2021 | $323.00M | +2.9% |
| Q4 FY2020 | Dec 31, 2020 | $566.00M | +36.1% |
| Q3 FY2020 | Sep 30, 2020 | $445.00M | +17.7% |
| Q2 FY2020 | Jun 30, 2020 | $348.00M | +61.9% |
| Q1 FY2020 | Mar 31, 2020 | $314.00M | -3.7% |
| Q4 FY2019 | Dec 31, 2019 | $416.00M | -6.7% |
| Q3 FY2019 | Sep 30, 2019 | $378.00M | -20.6% |
| Q2 FY2019 | Jun 30, 2019 | $215.00M | +10.8% |
| Q1 FY2019 | Mar 31, 2019 | $326.00M | -3.0% |
| Q4 FY2018 | Dec 31, 2018 | $446.00M | -15.0% |
| Q3 FY2018 | Sep 30, 2018 | $476.00M | +21.7% |
| Q2 FY2018 | Jun 30, 2018 | $194.00M | +50.4% |
| Q1 FY2018 | Mar 31, 2018 | $336.00M | +336.4% |
| Q4 FY2017 | Dec 31, 2017 | $525.00M | +132.3% |
| Q3 FY2017 | Oct 1, 2017 | $391.00M | +114.8% |
| Q2 FY2017 | Jul 2, 2017 | $129.00M | – |
| Q1 FY2017 | Apr 2, 2017 | $77.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $226.00M | – |
| Q3 FY2016 | Oct 2, 2016 | $182.00M | – |
See a number that looks wrong?